Full Agenda of the Week

The 11th WRIB will continue to feature the novel and unique 3-Day Sequential Program during the Main Workshop Days with no parallel sessions. However you have the flexibility to choose which Main Workshop Days based on your specific track of interest and learning needs.

In addition to the Sequential Main Workshop Days, 6 full-day Training Courses will spread throughout the week to give you many choices to combine Workshop Days and Courses to maximize your learning process at any level in your field of expertise.

Monday April 3, 2017

  • Training Course M-1:

    "In depth understanding of  Biomarkers' Challenges to maximize Method Development skills, troubleshooting and Validation to meet both Scientific & Regulatory current Requirements"

  • Training Course M-2:

    "Keeping pace with Antibody Drug Conjugates' (ADC) recent developments: Advanced Small & Large Molecules LCMS-based Workflows" - Accelerate your LCMS Method Development and Generate New Strategies in this unbelievably fast-expanding field

  • *Please note that Course M-1 and M-2 are in parallel from 8am to 5:30pm.

Tuesday April 4, 2017

  • MAIN WORKSHOP DAY 1:

    "SM, Peptides & SM Biomarkers by LCMS - Novel Solutions in Method Development & Regulatory Challenges"

  • Training Course T-1 for LBA scientists:

    "LBA Biotherapeutics Advanced Method Development Challenges, Solutions and New Industry Standards *A Brand NEW Course with NEW Case Studies*"

  • *Please note that Main Workshop Day 1 and Course T-1 are in parallel from 8am to 6pm.

Wednesday April 5, 2017

  • MAIN WORKSHOP DAY 2A

    "Hybrid LBA/LCMS (Immunoaffinity LCMS) for Biotherapeutics, Biomarkers and ADA - New Developments and Achievements"

  • MAIN WORKSHOP DAY 2B

    "Regulators' Advice - Latest Regulatory Inputs from Major/Influential Regulatory Agencies on New Guidances/Regulations and Findings"

  • *Please note that Day 2A and Day 2B are consecutive, NOT in parallel.

Thursday April 6, 2017

  • MAIN WORKSHOP DAY 3:

    " LBA ⁄ Cell-based Assays, LM Biomarkers Validation, and Immunogenicity - Challenges and Solutions"

  • Training Course Th-1 for LCMS scientists:

    "LCMS Small Molecules Sensitivity & Selectivity (S&S) Challenges, Solutions, and New Industry Standards *A Brand NEW Course with NEW Case Studies*"

  • *Please note that Main Workshop Day 3 and Course Th-1 are in parallel from 8am to 6pm.

Friday April 7, 2017

  • Training Course F-1:

    Advanced Immunogenicity of Biotherapeuticis: Coping with the Evolving Challenges and Overcoming Scientific & Regulatory Issues  - An in-depth highly focused training on mastering immunogenicity to design & develop the right ADA/Nab Assay for any specific program, from initial immunogenicity detection to late stage clinical trials ADA assessment tools incorporation

  • Training Course F-2:

    "Large Molecules Bioanalytical Method Development by LCMS Specifically and Systematically Designed for Scientists with LBA Background" - Learn LCMS Step by Step in order to Discover the Potential of LCMS as an Alternative / Complementary Technique to LBA

  • *Please note that Course F-1 and Course F-2 are in parallel from 8am to 5:30pm.

Agenda in Charts according to your Focus

 

 

Full Immersion Agenda Chart

LCMS Focus Agenda Chart

LBA Focus Agenda Chart

©2016 WRIB. All Rights Reserved.